Outset Medical, Inc.
OM
$9.98
-$1.03-9.36%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 113.69M | 114.73M | 116.43M | 125.08M | 130.38M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 113.69M | 114.73M | 116.43M | 125.08M | 130.38M |
| Cost of Revenue | 74.55M | 79.07M | 83.43M | 94.16M | 101.25M |
| Gross Profit | 39.14M | 35.66M | 33.00M | 30.92M | 29.13M |
| SG&A Expenses | 110.67M | 119.69M | 130.71M | 136.17M | 139.80M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 221.51M | 241.07M | 264.38M | 285.74M | 297.61M |
| Operating Income | -107.82M | -126.34M | -147.95M | -160.67M | -167.24M |
| Income Before Tax | -127.49M | -140.33M | -158.67M | -168.28M | -172.27M |
| Income Tax Expenses | 491.00K | 607.00K | 511.00K | 493.00K | 523.00K |
| Earnings from Continuing Operations | -127.98 | -140.94 | -159.18 | -168.77 | -172.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -127.98M | -140.94M | -159.18M | -168.77M | -172.80M |
| EBIT | -107.82M | -126.34M | -147.95M | -160.67M | -167.24M |
| EBITDA | -102.09M | -120.57M | -142.11M | -154.78M | -161.43M |
| EPS Basic | -37.32 | -41.55 | -47.13 | -50.67 | -52.42 |
| Normalized Basic EPS | -22.25 | -25.39 | -28.89 | -31.10 | -32.19 |
| EPS Diluted | -37.32 | -41.55 | -47.13 | -50.67 | -52.42 |
| Normalized Diluted EPS | -22.25 | -25.39 | -28.89 | -31.10 | -32.19 |
| Average Basic Shares Outstanding | 13.73M | 13.57M | 13.53M | 13.33M | 13.19M |
| Average Diluted Shares Outstanding | 13.73M | 13.57M | 13.53M | 13.33M | 13.19M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |